Comparison of healthcare costs in patients with psoriatic arthritis who received etanercept, etanercept plus methotrexate, infliximab, or infliximab plus MTX

被引：0
|
作者：
Dabbous, O. [1 ]
Rahman, M. [1 ]
Meissner, B. [2 ]
Thompson, H. [1 ]
Tang, B. [1 ]
机构：
[1] Centocor Inc, Hlth Econ & Clin Outcomes Res, Horsham, PA USA
[2] Xcenda Inc, Palm Harbor, FL USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2007年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：258 / 258
页数：1
相关论文
共 50 条
  • [1] A comparison of health care costs in patients with psoriatic arthritis (PSA) who received etanercept (ETA), ETA plus methotrexate (MTX), infliximab (INF), or inf plus MTX
    Dabbous, O.
    Rahman, M.
    Meissner, B. L.
    Thompson, H.
    Tang, B.
    VALUE IN HEALTH, 2007, 10 (03) : A118 - A119
  • [2] Comparison of healthcare costs in patients with ankylosing spondylitis who received etanercept or infliximab therapy
    Rahman, M.
    Tang, B.
    Meissner, B.
    Thompson, H.
    Dabbous, Q.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 272 - 272
  • [3] Comparison of healthcare costs in patients with ankylosing spondylitis who received etanercept or infliximab therapy
    Tang, B.
    Rahman, M.
    Meissner, B.
    Thompson, H.
    Karpovich, N.
    Dabbous, O.
    RHEUMATOLOGY, 2008, 47 : II118 - II118
  • [4] Effect of Etanercept, Infliximab and Methotrexate in the Treatment of Arthritis
    Wang, L.
    Liu, Y.
    Su, X.
    Liu, S.
    DRUG RESEARCH, 2015, 65 (02) : 96 - 100
  • [5] Predictors for terminating therapy of etanercept and infliximab in psoriatic arthritis patients
    Kristensen, L. E.
    Nilsson, J.
    Jacobsson, L. T. H.
    Saxne, T.
    Compagno, M.
    Geborek, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 : 222 - 222
  • [6] Psoriatic arthritis patients doing better on infliximab than etanercept
    Smith, N.
    Gadsby, K.
    Deighton, C.
    RHEUMATOLOGY, 2007, 46 (04) : 721 - 722
  • [7] COMPARISON OF HEALTHCARE COSTS BETWEEN RHEUMATOID ARTHRITIS PATIENTS TREATED WITH INFLIXIMAB, ETANERCEPT AND ADALIMUMAB IN NORDIC SETTING
    Gokhale, S. B.
    Cassel, T.
    Mahon, R.
    Balkin, P. E.
    Singh, S.
    Bhattacharyya, S.
    Handin, J.
    Mendoza, C.
    VALUE IN HEALTH, 2016, 19 (07) : A535 - A535
  • [8] Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review
    Woolacott, N. F.
    Khadjesari, Z. C. S.
    Bruce, I. N.
    Riemsma, R. P.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2006, 24 (05) : 587 - 593
  • [9] Predictors for terminating therapy of etanercept and infliximab in psoriatic arthritis patients.
    Kristensen, Lars Erik
    Geborek, Pierre
    Nilsson, Jan- ke
    Saxne, Tore
    Compagno, Michele
    Jacobsson, Lennart
    ARTHRITIS AND RHEUMATISM, 2006, 54 (09): : S721 - S722
  • [10] Adalimumab, etanercept and infliximab are equally effective treatments for patients with psoriatic arthritis
    Dafna D Gladman
    Nature Clinical Practice Rheumatology, 2008, 4 : 510 - 511
12345